Course:
CME Credits: 0.50
Released: 2025-05-13
Oncolytic therapy was first introduced in the field of oncology a decade ago. Recently, advancements have been made in oncolytic therapy, with the promise of potentially transforming the melanoma treatment landscape. In anticipation of an expanded role for oncolytic therapy, providers need updates on the mechanism of action, efficacy, safety, and practical aspects of each regimen. Advanced practice providers often spearhead the adoption of technologies such as intralesional injections in health systems. Therefore, they need up-to-date education about oncolytic therapies, opportunities to develop competency in intralesional injections, as well as support for credentialing. This curriculum, which carries the Advanced Practitioner Society for Hematology and Oncology (APSHO) Seal of Acceptance, contains didactic content on oncolytic therapies, instructional videos on techniques for intralesional injections, supportive strategies for credentialing, as well as a future opportunity for hands-on training for intralesional injections at JADPRO Live. We trust that you will find this content helpful in the adoption of an expanded role for oncolytic therapies in melanoma.
Upon completion of this activity, participants should be better able to:
View Full Course